相关实验视频

Updated: Jul 19, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

病毒载体表达介质素2用于癌症免疫疗法

Hongbin Wang^1,2, Mia Borlongan², Akseli Hemminki^3,4,5

¹Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA.

Human gene therapy

|August 14, 2023

概括

瘤病毒向瘤输送介质素2 (IL-2),增强癌症免疫疗法. 这种方法克服了IL-2治疗的局限性,显示出治疗转移性癌症的希望.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
病毒学病毒学

背景情况:

干白素2 (IL-2) 是T细胞功能的关键细胞因子,并已获得FDA批准用于治疗转移性黑色素瘤和细胞癌.
高剂量的IL-2疗法面临诸多挑战,包括血清半衰期短,瘤积累不良和严重的毒性.

研究的目的:

为了审查Interleukin 2-表达病毒载体用于癌症治疗的治疗潜力.
要总结这些工程瘤病毒的抗瘤作用机制.

主要方法:

对经过改造以传递IL-2的型病毒进行临床前和临床研究的综述.
分析涉及IL-2与病毒载体内的其他抗癌转基因共同表达的研究.

主要成果:

瘤解毒病毒 (OVs) 能够安全有效地将IL-2输送到瘤微环境中.
工程化OV可以增强IL-2的免疫特性,并显示出有前途的抗瘤效果.

结论:

表达IL-2的病毒载体在癌症免疫治疗中是一个有前途的策略.
这种方法为传统IL-2疗法的局限性提供了潜在的解决方案,增强了抗瘤反应.

关键词:

癌症癌症癌症癌症癌症免疫疗法免疫疗法介质蛋白 2 2 介质蛋白在当地提供本地交付服务.科性病毒病毒.有关炎症的细胞因子.病毒载体病毒载体病毒疗法病毒疗法

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...